[1]
2022. Pharmaceutical attention to the risks of inappropriate use of marijuana in the treatment of depression. Research, Society and Development. 11, 17 (Dec. 2022), e63111738877. DOI:https://doi.org/10.33448/rsd-v11i17.38877.